Welcome to our dedicated page for Well Health Tech news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on Well Health Tech stock.
WELL Health Technologies Corp. reports developments across a Canadian outpatient healthcare platform, digital health software and related technology-enabled services. The company operates a large owned clinic network in Canada and reports recurring updates on patient visits, Canadian Patient Services, primary care and specialty care performance, acquisitions, clinic transformation activity and financial results.
WELL’s news also covers WELLSTAR healthcare technology products, including electronic medical records, AI-powered clinical tools, patient engagement, eReferral and IT managed services. Other recurring themes include HEALWELL AI, CYBERWELL cybersecurity services, virtual cardiology through CardiologyNow, partnerships for remote cardiac monitoring, conference participation and financing capacity for the company’s healthcare operations.
WELL Health (OTCQX: WHTCF) appointed healthcare executive Derek Clark as Chief Operating Officer, effective immediately. Clark brings over 20 years of leadership across digital health, diagnostic imaging, clinical services, and healthcare technology, with prior senior roles at Calian Group and GE Healthcare.
As COO, he will report to CEO Hamed Shahbazi and focus on operational execution, scalability, integration, and enterprise performance management across WELL's healthcare and digital health portfolio.
WELL Health (TSX: WELL, OTCQX: WHTCF) received TSX approval for a renewed Normal Course Issuer Bid (NCIB) and entered an automatic share purchase plan (ASPP) with a broker.
The NCIB allows repurchase of up to 12,770,172 shares (5% of 255,408,705) from May 21, 2026 to May 20, 2027, with daily TSX purchases capped at 383,933 shares. All repurchased shares will be cancelled.
WELL Health (OTCQX: WHTCF) reported Q1 2026 revenue of $368.3M, up 25% year-over-year, with Adjusted EBITDA of $43.1M (12% margin). Canadian Patient Services revenues rose 30% to $130.3M, and total patient visits reached 1.9M (+17% YoY). The company reaffirmed 2026 guidance: $1.55–1.65B revenue and $175–185M Adjusted EBITDA, and noted a Canadian clinics run rate exceeding $500M.
WELL Health Technologies (TSX: WELL / OTCQX: WHTCF) will release Fiscal Q1 2026 results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. A conference call and simultaneous webcast are scheduled the same day at 5:00 PM ET / 2:00 PM PT.
Management participants include Hamed Shahbazi, Chairman and CEO, and Eva Fong, CFO. Dial-in details and webcast registration are provided for investors and analysts.
WELL Health (OTCQX: WHTCF) reported record Canadian performance in Q1-2026: ~1.27 million patient visits (33% YoY, 13% organic) and Primary Care Adjusted EBITDA margins of ~8%, up ~200 basis points year-over-year. Affiliate clinics expanded to 74 locations and the provider base reached 3,158.
CardiologyNow virtual consultations grew 65% YTD; results are preliminary and subject to final reporting and adjustment.
WELL (OTCQX: WHTCF) subsidiary CYBERWELL launched its CYDEcore™ Fusion platform and announced a unified operating model consolidating Cycura, Seekintoo, and Proack into one cybersecurity business.
Key milestones include SOC2 Type I certification, Microsoft Security Solutions Partner designation, and an XSOAR-based managed security platform with multiple enterprise clients live.
WELL Health Technologies (OTCQX: WHTCF) and majority-owned subsidiary WELLSTAR will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 21-22, 2026.
WELL presents April 22 at 9:30-10:00 AM ET (Room 104 C/D, presenter Hamed Shahbazi). WELLSTAR presents April 22 at 10:30-11:00 AM ET (Room 104 C/D, presenter Amir Javidan). Both companies will deliver corporate presentations and hold one-on-one investor meetings.
WELL Health (OTCQX: WHTCF) partnered with AliveCor to provide AI-powered Kardia ECG monitoring with cardiologist-reviewed Clinician Reviews for Canadian users starting April 2, 2026.
Canadian-registered cardiologists in WELL’s network review Kardia ECGs within 24 hours, supplementing AI results (Kardia: >350 million ECGs recorded; AI detects three common arrhythmias) and generating clinical services revenue per review.
WELL Health (TSX: WHTCF) supports Ontario’s plan for a provincewide Primary Care Medical Record system backed by $3.4 billion in primary care funding to connect about 2 million more residents by 2029. WELL says its majority-owned WELLSTAR already supports ~8,165 physicians and 1,669 clinics in Ontario via provincially certified EMRs.
WELL intends to participate in the Province’s open, multi-vendor procurement led by Supply Ontario, citing its OSCAR Pro, Nexus AI™, OceanMD and broader WELL ecosystem as fit-for-purpose for interoperability, referrals, AI-enabled workflows and cybersecurity.
WELL Health Technologies (OTCQX: WHTCF) reported record FY2025 results with $1.40B revenue (+52% YoY) and $203.7M Adjusted EBITDA (+336% YoY; 14.5% margin). Canadian Patient Services revenue rose to $444.3M (+39%) with Adjusted EBITDA of $58.1M (+43%). Operating free cash flow to shareholders was $58.2M. Management provided 2026 guidance of $1.55–1.65B revenue and $175–185M Adjusted EBITDA, and completed credit facility expansion to $400M. The company cited acquisitions, organic growth and HEALWELL inclusion as drivers and plans a WELLSTAR spin-out.